Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study.

Open Forum Infect Dis · 2025 · PMC11934920 · PMID 40134633

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The incidence of CDI was numerically higher with ampicillin-sulbactam (0.6% vs 0.4%; RD, 0.2% [95% CI, .0%–.4%]; OR, 1.45, [.99–2.11]), but this difference did not reach statistical significance ( Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.